Effect of combination therapy with aminoglutethimide and hydrocortisone on prostate-specific antigen respons in metastatic prostatic cancer refractory to standard endocrine therapy

Wim Kruit; Gerrit Stoter; Jan Klijn

doi:10.1097/00001813-200410000-00004

Effect of combination therapy with aminoglutethimide and hydrocortisone on prostate-specific antigen respons in metastatic prostatic cancer refractory to standard endocrine therapy

Wim Kruit
, Gerrit Stoter
, Jan Klijn

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

29 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	843-847
Number of pages	5
Journal	Anti-Cancer Drugs
Volume	15
DOIs	https://doi.org/10.1097/00001813-200410000-00004
Publication status	Published - 2004

Research programs

EMC MM-03-86-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/00001813-200410000-00004

http://hdl.handle.net/1765/62580

Cite this

@article{6c6ee0aaf80f4483aaa169417f31ebce,

title = "Effect of combination therapy with aminoglutethimide and hydrocortisone on prostate-specific antigen respons in metastatic prostatic cancer refractory to standard endocrine therapy",

author = "Wim Kruit and Gerrit Stoter and Jan Klijn",

year = "2004",

doi = "10.1097/00001813-200410000-00004",

language = "Undefined/Unknown",

volume = "15",

pages = "843--847",

journal = "Anti-Cancer Drugs",

issn = "0959-4973",

publisher = "Lippincott Williams \& Wilkins",

}

TY - JOUR

T1 - Effect of combination therapy with aminoglutethimide and hydrocortisone on prostate-specific antigen respons in metastatic prostatic cancer refractory to standard endocrine therapy

AU - Kruit, Wim

AU - Stoter, Gerrit

AU - Klijn, Jan

PY - 2004

Y1 - 2004

U2 - 10.1097/00001813-200410000-00004

DO - 10.1097/00001813-200410000-00004

M3 - Article

SN - 0959-4973

VL - 15

SP - 843

EP - 847

JO - Anti-Cancer Drugs

JF - Anti-Cancer Drugs

ER -